Nisa Investment Advisors
MRNA icon

Nisa Investment Advisors’s Moderna MRNA Stock Holding History

Nisa Investment Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.85M Buy
26,355
+923
+4% +$47.8K 0.01% 642
2026
Q1 		$1.29M Buy
25,432
+4,263
+20% +$199K ﹤0.01% 719
2025
Q4 		$624K Buy
21,169
+4,923
+30% +$134K ﹤0.01% 938
2025
Q3 		$420K Buy
16,246
+5,417
+50% +$151K ﹤0.01% 1065
2025
Q2 		$299K Sell
10,829
-23,279
-68% -$613K ﹤0.01% 1115
2025
Q1 		$967K Buy
34,108
+21,330
+167% +$757K ﹤0.01% 826
2024
Q4 		$531K Sell
12,778
-2,113
-14% -$101K ﹤0.01% 1048
2024
Q3 		$995K Sell
14,891
-63,639
-81% -$5.84M 0.01% 852
2024
Q2 		$9.33M Buy
78,530
+41,136
+110% +$5.21M 0.06% 291
2024
Q1 		$3.98M Buy
37,394
+13,823
+59% +$1.39M 0.03% 513
2023
Q4 		$2.34M Sell
23,571
-27,949
-54% -$2.35M 0.02% 620
2023
Q3 		$5.32M Sell
51,520
-4,925
-9% -$549K 0.04% 389
2023
Q2 		$6.86M Sell
56,445
-13,006
-19% -$1.73M 0.05% 345
2023
Q1 		$10.7M Sell
69,451
-1,441
-2% -$238K 0.08% 257
2022
Q4 		$12.7M Buy
70,892
+5,305
+8% +$867K 0.1% 234
2022
Q3 		$7.96M Buy
65,587
+2,283
+4% +$346K 0.07% 282
2022
Q2 		$9.04M Sell
63,304
-17,840
-22% -$2.55M 0.08% 255
2022
Q1 		$14M Sell
81,144
-4,053
-5% -$682K 0.1% 206
2021
Q4 		$14.4M Buy
85,197
+9,876
+13% +$2.89M 0.11% 196
2021
Q3 		$29M Buy
75,321
+27,959
+59% +$10.3M 0.18% 111
2021
Q2 		$11.1M Sell
47,362
-4,800
-9% -$858K 0.07% 257
2021
Q1 		$6.83M Sell
52,162
-12,900
-20% -$1.87M 0.04% 354
2020
Q4 		$6.8M Buy
65,062
+52,509
+418% +$5.31M 0.04% 362
2020
Q3 		$888K Sell
12,553
-5,670
-31% -$395K 0.01% 845
2020
Q2 		$1.17M Buy
18,223
+3,198
+21% +$175K 0.01% 741
2020
Q1 		$450K Buy
15,025
+7,100
+90% +$163K 0.01% 954
2019
Q4 		$155K Buy
+7,925
New +$141K ﹤0.01% 1368

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Nisa Investment Advisors's MRNA Position: Q2 2026 in Review

Nisa Investment Advisors increased its Moderna (MRNA) stake by 3.6% in Q2 2026, buying an estimated $47.8K and bringing the position to 26,355 shares worth $1.85M. The position accounts for 0.01% of the portfolio, ranked #642.

Nisa Investment Advisors first reported a position in MRNA in Q4 2019 and has held it in 27 quarters since. The position peaked at $29M in Q3 2021. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Nisa Investment Advisors held 26,355 shares of Moderna worth $1.85M as of Q2 2026.
  • Nisa Investment Advisors bought 923 Moderna shares in Q2 2026, an estimated $47.8K.
  • Moderna made up 0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #642 holding.
  • Nisa Investment Advisors first reported a position in Moderna in Q4 2019 and has held it in 27 quarters since.
  • Nisa Investment Advisors's Moderna position peaked at $29M in Q3 2021.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.